7697.5000 13.50 (0.18%)
NSE Sep 24, 2025 13:41 PM
Volume: 111.2K
 

7697.50
0.18%
Prabhudas Lilladhar
to ensure non-compete and synergy alignment between AHEL and NewCo, with clear role demarcation - AHEL to focus on core healthcare and NewCo on pharmacy & digital. The demerger was on expected lines and is aimed to unlock value by creating a focused, high-growth platform in the pharmacy and digital healthcare space, which is more consumer centric in nature. The stake sale in HealthCo to Advent and merger with Keimed are a positive step and will lead to an integrated pharmacy distribution business. Scale-up in...
Apollo Hospitals Enterprise Ltd. is trading below its 30 day SMA of 7773.7
More from Apollo Hospitals Enterprise Ltd.
Recommended